Park Ha Biological Technology Co., Ltd.
PHH · NASDAQ
4/30/2025 | 10/31/2024 | 4/30/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Market Cap | $375,184 | $0 | $0 | $0 |
| - Cash | $1,351 | $547 | $932 | $1,034 |
| + Debt | $91 | $70 | $20 | $31 |
| Enterprise Value | $373,924 | -$477 | -$912 | -$1,002 |
| Revenue | – | – | – | – |
| % Growth | – | – | – | – |
| Gross Profit | – | – | – | – |
| % Margin | – | – | – | – |
| EBITDA | – | – | – | – |
| % Margin | – | – | – | – |
| Net Income | – | – | – | – |
| % Margin | – | – | – | – |
| EPS Diluted | – | – | – | – |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |